Clin2
NCT07626606Possibly a fitRecruiting

Gut Health and Rotavirus Vaccine Response in Adults

Feasibility StudyVaccine Immune ResponseRota Virus GastroenteritisTranscriptomics

Part of Digestive system, Immune system & allergy, Infections clinical trials.

This study examines how the health of your digestive system affects how well your body responds to an oral rotavirus vaccine (a vaccine given by mouth to protect against rotavirus infection). You'll have two endoscopy procedures—a camera test to look inside your digestive tract—and provide samples to help researchers understand this connection.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
43 people
Ages
18 years to 50 years
Study type
Observational

Who can take part

  • You are between 18 and 50 years old
  • You live in Lusaka district, Zambia, and can attend scheduled visits
  • You are willing to have two endoscopy procedures (a camera tube inserted to examine your gut) with sample collection
  • You do not have an active digestive disease requiring treatment, such as stomach ulcers or active bleeding
  • You are not pregnant, breastfeeding, or planning to become pregnant in the 30 days after vaccination
  • You do not have a severe immune system problem, uncontrolled high blood pressure, or heart/lung disease that would make endoscopy unsafe

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07107516Recruiting· Phase 1
Testing an oral cholera vaccine in healthy adults

This study tests an oral cholera vaccine called PanChol in healthy adults. The goal is to see if it's safe and how the body responds. It may help protect against cholera, a serious diarrheal illness.

Lusaka, Lusaka Province
NCT06967272Recruiting· Phase 2
Oral rotavirus vaccine trial for healthy infants

This trial tests an oral vaccine given as drops to protect babies against rotavirus, a common cause of severe diarrhea. It is for healthy infants aged 6 to 12 weeks who have not had the rotavirus vaccine or infection before.

Wuhan, Hubei
NCT07418229Not yet recruiting· Phase 1
Safety study of an RSV mRNA vaccine in healthy adults

This study tests a new RSV vaccine to see if it is safe for healthy adults. It uses mRNA technology to help your body build protection against RSV, a common respiratory virus.

Changzhi, Shanxi
NCT07618325Not yet recruiting
Testing immune response to a new RSV vaccine

This study tests how your body's immune system responds to a new respiratory syncytial virus (RSV) vaccine. RSV is a common virus that causes respiratory infections, especially in older adults. The vaccine may help protect you from RSV disease.

NCT03705585Recruiting· Phase 4
Check how typhoid and cholera vaccines work in adults

This study gives (or follows) typhoid and/or cholera vaccines and measures how your immune system responds. It is done in adults who are already scheduled for an upper endoscopy (EGD) and/or colonoscopy, using small tissue samples if appropriate.

Baltimore, Maryland
NCT07417657Not yet recruiting
RSV infection and gut bacteria in Vietnamese infants

This study looks at how gut bacteria and the immune system respond in infants with severe RSV infection, to better understand the disease and find new ways to treat or prevent it.

Hanoi

Hear when a new Transcriptomics trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.